Breast cancer research and treatment
Breast Cancer Research and Treatment is a long-established Springer journal spanning breast cancer biology, epidemiology and clinical management, read by breast oncologists and researchers.
Overview
Breast Cancer Research and Treatment has been published since 1981, first by Kluwer Academic in Dordrecht, the Netherlands, and now by Springer, which Crossref lists as the publisher. As its title indicates, it spans both breast cancer research and treatment, and it is one of the longest-running journals devoted to the disease. The NLM record lists it as a Netherlands serial that is indexed in MEDLINE; it is not listed in DOAJ.
Andrew Wardley is a breast oncologist involved in the PERSEPHONE trial of shorter trastuzumab.
Breast cancer biologist and Chief Scientific Officer of the Breast Cancer Research Foundation, directing its global research grant portfolio.
Lori Pierce is a breast radiation oncologist and ASCO past president focused on equity in cancer care.
Breast medical oncologist and Deputy CEO for clinical operations at the National Cancer Centre Singapore, an international leader in triple-negative breast cancer trials.
A senior breast cancer specialist who has led Japanese arms of adjuvant and metastatic breast cancer trials for two decades.
Pages like this
not linked directly; found by shared links- JournalBreast cancer
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalThe breast journal
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalThe Breast
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalClinical breast cancer
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalJournal of mammary gland biology and neoplasia
Shares Ductal carcinoma in situ (DCIS), PubMed & Europe PMC, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- JournalBreast cancer research
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalJournal of breast imaging
Shares Ductal carcinoma in situ (DCIS), PubMed & Europe PMC, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- TermMastectomy
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).